Armata Pharmaceuticals (ARMP) Restructuring Costs (2014 - 2026)

Armata Pharmaceuticals (ARMP) has 5 years of Restructuring Costs data on file, last reported at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Restructuring Costs rose 8.05% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $7.7 million (down 2.49% YoY), and the FY2025 full-year result was $7.5 million, down 8.93% from the prior year.
• Restructuring Costs declined to $2.0 million in Q1 2026, from $2.3 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $2.3 million in Q4 2025 to a low of $1.4 million in Q2 2025.
• A 3-year average of $2.0 million and a median of $2.0 million in 2024 frame the typical range for Restructuring Costs.
• Across the five-year window, Restructuring Costs slipped 23.55% in 2025 and rose 8.05% in 2026, its largest moves.
• Tracing ARMP's Restructuring Costs over 3 years: stood at $2.2 million in 2024, then climbed by 4.43% to $2.3 million in 2025, then slipped by 11.54% to $2.0 million in 2026.
• Business Quant data shows ARMP's Restructuring Costs at $2.0 million in Q1 2026, $2.3 million in Q4 2025, and $2.0 million in Q3 2025.